Press Releases
Cyxone will leverage IND and use FDA pre-review for Covid-19 phase 2 trial
24 Sep, 2021 11:19 CESTRegulatoryMARCyxone appoints Cornel Pater as new Chief Medical Officer
1 Sep, 2021 11:56 CESTRegulatoryInterim Report 1 January to 30 June 2021
27 Aug, 2021 08:30 CESTRegulatoryCyxone recruits key members to the clinical development team
26 Aug, 2021 13:34 CESTCyxone announces Rabeximod in Covid-19 Phase 2 trial closed, data to be reported in Q3
14 Jul, 2021 08:41 CESTRegulatory